Human medicinal products
SPC PL
Veterinary medicinal
products
SPC PL
Herbal medicinal products
SPC PL
Name of the medicinal
product
A B C D E F G
H I J K L M N
O P Q R S T U
V W X Y Z Å Ä Ö
Name of the medicinal
product

Marketing authorisation
holder

Marketing authorisation
number

ATC Code Codes

Free text search

Active agent

Pharmaceutical form

Adverse effect

Therapeutic indication

Contraindication

Insert text in the fields in Finnish


Summaries of Product Characteristics (SPC) for Human medicinal products

The summaries of product characteristics (SPC) contain the information relevant to the use of the medicinal products and of importance to health care professionals. The SPCs are published in Finnish; the use of Finnish key words in the search fields is therefore recommended.

Some of the medicinal products contain a condition relevant to the prescribing of the product and not always found in the SPC. The conditions for prescribing and the products covered by this condition are found in the FimeaWeb search.

The SPCs processed as part of the EU centralised marketing authorisation procedure are published by the European Medicines Agency, EMA. Fimea's service contains links to the documents on medicinal products (EPAR PI) on the EMA website. Drugs belonging to the centralised authorisation procedure can be searched in Fimea's service by using an alphabetical list or by entering the product name or ATC code.

The material being published is not necessarily complete or up-to-date due to the technical quality of files submitted to the Finnish Medicines Agency Fimea or earlier to the National Agency for Medicines and the delays in delivery. For this reason, Fimea cannot guarantee that the document on the Internet fully complies with the summary of product characteristics and package leaflet officially approved by a desicion for a marketing authorisation. Only the hard copies of the SPCs and the PLs, which are in accordance with the marketing authorisation, are conclusive.


Summaries of Product Characteristics 151 - 180 of 356
Previous 30    |  1  2  3  4  5  6  7  8  9  10  11  12  |  Next 30   >    
Package
leaflet
Status for
supply
Name of the medicinal product

PL

Resepti

Sirdalud 2 mg, 4 mg tabletti SPC 2020-08-26

PL

Resepti

Sirdalud Retard 6 mg depotkapseli, kova SPC 2020-08-26

European Medicines Agency's website:
Sirturo - EMA: EPAR PI
Finnish Swedish

European Medicines Agency's website:
Sitagliptin Accord - EMA: EPAR PI
Finnish Swedish

PL

Resepti

Sitagliptin Avansor 50 mg, 100 mg tabletti, kalvopäällysteinen SPC 2022-01-19

PL

Resepti

Sitagliptin Glenmark 25 mg, 50 mg, 100 mg tabletti, kalvopäällysteinen SPC 2021-08-17

PL

Resepti

Sitagliptin Grindeks 25 mg, 50 mg, 100 mg tabletti, kalvopäällysteinen SPC 2022-02-10

PL

Resepti

Sitagliptin Hexal 25 mg, 50 mg, 100 mg tabletti, kalvopäällysteinen SPC 2022-03-15

PL

Resepti

Sitagliptin Krka 25 mg, 50 mg, 100 mg tabletti, kalvopäällysteinen SPC 2022-03-04

PL

Resepti

Sitagliptin Mylan 25 mg, 50 mg, 100 mg tabletti, kalvopäällysteinen SPC 2022-02-15

PL

Resepti

Sitagliptin Orion 25 mg, 50 mg, 100 mg, tabletti, kalvopäällysteinen SPC 2020-12-02

PL

Resepti

Sitagliptin ratiopharm 25 mg, 50 mg, 100 mg tabletti, kalvopäällysteinen SPC 2021-10-25

PL

Resepti

Sitagliptin Sandoz 25 mg, 50 mg, 100 mg tabletti, kalvopäällysteinen SPC 2022-05-30

PL

Resepti

Sitagliptin STADA 25 mg, 50 mg, 100 mg tabletti, kalvopäällysteinen SPC 2022-07-19

European Medicines Agency's website:
Sitagliptin SUN - EMA: EPAR PI
Finnish Swedish

PL

Resepti

Sitagliptin Zentiva 25 mg, 50 mg, 100 mg tabletti, kalvopäällysteinen SPC 2021-12-17

PL

Resepti

Sitagliptin-Metformin Glenmark 50 mg-850 mg, 50 mg-1000 mg tabletti, kalvopäällysteinen SPC 2022-01-25

PL

Resepti

Sitagliptin-Metformin Grindeks 50 mg-850 mg, 50 mg-1000 mg tabletti, kalvopäällysteinen SPC 2022-04-22

PL

Resepti

Sitagliptin-Metformin Hexal 50 mg-850 mg, 50 mg-1000 mg tabletti, kalvopäällysteinen SPC 2022-03-14

PL

Resepti

Sitagliptin-Metformin Krka 50 mg-850 mg, 50 mg-1000 mg tabletti, kalvopäällysteinen SPC 2022-04-14

PL

Resepti

Sitagliptin-Metformin ratiopharm 50 mg-850 mg, 50 mg-1000 mg tabletti, kalvopäällysteinen SPC 2021-12-16

PL

Resepti

Sitagliptin-Metformin Reddy 50 mg-850 mg, 50 mg-1000 mg tabletti, kalvopäällysteinen SPC 2022-06-23 Uusi

PL

Resepti

Sitagliptin-Metformin Sandoz 50 mg-850 mg, 50 mg-1000 mg tabletti, kalvopäällysteinen SPC 2022-03-14

PL

Resepti

Sitagliptin-Metformin STADA 50 mg-850 mg, 50 mg-1000 mg tabletti, kalvopäällysteinen SPC 2021-10-04

PL

Resepti

Sitagliptin-Metformin Zentiva 50 mg-850 mg, 50 mg-1000 mg tabletti, kalvopäällysteinen SPC 2022-03-15

European Medicines Agency's website:
Sitagliptin/Metformin Hydrochloride Accord - EMA: EPAR PI
Finnish Swedish

European Medicines Agency's website:
Sitagliptin/Metformin hydrochloride Mylan - EMA: EPAR PI
Finnish Swedish

PL

Resepti

Sitavig 50 mg bukkaalitabletti, kiinnittyvä SPC 2022-07-25

European Medicines Agency's website:
Sivextro - EMA: EPAR PI
Finnish Swedish

European Medicines Agency's website:
Sixmo - EMA: EPAR PI
Finnish Swedish

Previous 30    |  1  2  3  4  5  6  7  8  9  10  11  12  |  Next 30   >